ClinicalTrials.gg
CompletedNCT01866969Updated Oct 19, 2026

Quality of Life in Caregivers of Hospitalized Older Patients With Cancer

An interventional study of questionnaire administration and quality-of-life assessment in Hematopoietic/Lymphoid Cancer and Unspecified Adult Solid Tumor, Protocol Specific, sponsored by City of Hope Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by City of Hope Medical Center · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 19, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
211
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 25 studies in Hematologic Neoplasms by City of Hope Medical Center — 2 open to participants now, 13 under way, 1 of them phase 3. Hematologic Neoplasms · City of Hope Medical Center.

Enrollment
2nd of 19
211 · median 20
Started
2013
with 1 other
No phase
8 of 25
none open now
Registered
2nd of 25
by date

Among the 25 studies in Hematologic Neoplasms by City of Hope Medical Center, this one is the 2nd largest by enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2013, is one of 8 with no phase, and was the 2nd registered.

Hematologic Neoplasms

1,449 studies on the registry are indexed under Hematologic Neoplasms; 422 are open to participants now.

Browse Hematologic Neoplasms studies →

Open to participants now

2 of the 25 studies in Hematologic Neoplasms by City of Hope Medical Center are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 313 Hematologic Neoplasms studies recruiting now, 209 (67%) set no upper age limit and 78 (25%) stop at 75 or younger; 81 take children under 18; 34 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Hematologic Neoplasms by City of Hope Medical Center, or all of them as a file.
02

Study summary

This clinical trial studies quality of life in caregivers of hospitalized older patients with cancer.

Read the detailed description

PRIMARY OBJECTIVES:

I. Identify patient and caregiver factors associated with increased caregiver burden and decreased quality of life in caregivers of older adults with cancer.

SECONDARY OBJECTIVES:

I. Determine characteristics of informal caregivers of older adults with cancer admitted to hospital.

II. Determine type and amount of care informal caregivers provide for older adults with cancer admitted to hospital.

III. Determine quality of life in informal caregivers of older adults with cancer admitted to hospital.

IV. Identify caregiver needs, both informational and resource related. V. Explore the association between re-admission to the hospital within 30 days and caregiver burden.

VI. Explore whether feedback of information attained from the assessment of the caregiver influences services implemented by the health care team.

VII. Determine reasons for non-participation.

OUTLINE:

Caregivers complete a questionnaire about their sociodemographics, physical health, social supports, social activity, mental health and caregiver burden. They will also provide an assessment of the person they care for.

03

Conditions studied

  • Hematopoietic/Lymphoid Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • PATIENT: Age >= 65 years old
  • PATIENT: Diagnosis of cancer (solid or hematologic )
  • PATIENT: Be able to provide
  • PATIENT: Unplanned admission to hospital
  • CAREGIVER: Primary caregiver (person who provides all of the majority of the unpaid care for the care recipient)
  • CAREGIVER: Be able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • PATIENT: Planned admission to hospital for treatment (chemotherapy, transplant)
  • CAREGIVER: Not fluent in English (because not all questionnaires have been validated in other languages)
  • CAREGIVER: Paid and trained to care for the patient
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
211 participants (actual)

Study arms

  • Experimental
    Supportive care (quality of life questionnaire)

    Caregivers complete a self-administered questionnaire about factors associated with increased caregiver burden and decreased quality of life.

    Other: questionnaire administration · Procedure: quality-of-life assessment

Interventions

  • Otherquestionnaire administration

    Ancillary studies

  • Procedurequality-of-life assessment

    Ancillary studies

    Also known as: quality of life assessment

06

What researchers measure

Primary outcomes

  1. Caregiver burden and caregiver quality of life as measured by the Caregiver Quality of Life-Cancer Index

    Univariate analyses will be performed to test differences in the Caregiver Quality of Life-Cancer Index (CQOLC) total score and score of each domain (burden, distinctiveness, positive adaption, and financial concern) across categorical variables (analysis of variance \[ANOVA\]), and simple linear regression will be used to test association of CQOLC total score with continuous and categorical variables.

    Time frame: Up to 1 year

07

Study locations

1 site
  • City of Hope Medical Center
    Duarte, California 91010, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2013 to primary completion in May 2014, 10 months.

Of 186 non-industry interventional studies with no phase under Hematologic Neoplasms, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 125. This study's 10 months is below that.

Counting every sponsor, half of 192 studies reached it within 40 months; a quarter within 21 and three quarters within 82.

Start moved once since we started tracking on Sep 25, 2026: Jun 2013 → Jul 2013, on Oct 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2013
First posted
Jun 3, 2013
StartActual
Jul 1, 2013was Jun 2013
Primary completionActual
May 1, 2014
CompletionActual
May 1, 2014
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jun 2013→Jul 1, 2013 (actual)
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Start date Jun 2013→Jul 1, 2013 (now actual)
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT01866969
Responsible party
Sponsor
First posted
Jun 3, 2013
Start date
Jul 1, 2013
Primary completion
May 1, 2014
Completion
May 1, 2014
Last update
Oct 19, 2026

Study contacts

Arti Hurria, MD
principal investigator · City of Hope Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion